Skip to main content
Premium Trial:

Request an Annual Quote

Waters, Thermo to Integrate UPLC and Mass Spec Products

NEW YORK, March 6 (GenomeWeb News) - Waters and Thermo Electron have entered into an agreement to integrate the Waters Acquity Ultra Performance Liquid Chromatography system with Thermo's line of mass spectrometers, the companies said today.

 

The agreement includes Thermo's Finnigan TSQ Quantum, LTQ Linear Ion Trap, LTQ FT Hybrid Linear Trap/Fourier Transform ICR and LTQ Orbitrap hybrid mass spectrometers.

 

The use of UPLC with mass spec is expected to increase throughput and performance, the companies said.

 

"UPLC peaks are narrower and sharper, signal-to-noise ratios are higher, and run times are shorter -- which are all key factors in enhancing the performance of virtually any mass spectrometer," said Rohit Khanna, vice president of worldwide marketing at Waters, in a statement.

 

Additional terms of the agreement were not provided.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.